Citadel Advisors - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$4,167,187
+46.5%
108,464
-11.7%
0.00%0.0%
Q1 2023$2,844,696
-79.1%
122,881
-76.3%
0.00%
-66.7%
Q4 2022$13,610,035
+39.3%
519,467
+4.6%
0.00%
+50.0%
Q3 2022$9,768,000
+32.3%
496,819
+17.7%
0.00%0.0%
Q2 2022$7,385,000
+641.5%
422,251
+593.9%
0.00%
Q1 2022$996,000
+390.6%
60,849
+389.6%
0.00%
Q4 2021$203,000
-89.5%
12,428
-91.8%
0.00%
Q3 2021$1,942,000
-53.8%
152,183
-48.8%
0.00%
-100.0%
Q2 2021$4,200,000
-50.8%
297,422
-46.1%
0.00%
-50.0%
Q1 2021$8,528,000
-4.8%
551,756
-2.3%
0.00%0.0%
Q4 2020$8,960,000564,8980.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Parallel Advisors, LLC 5$00.00%
View complete list of CHINOOK THERAPEUTICS INC shareholders